Search
for
Sort by
Research 31–60 of 1000+
- FDA Reports of Alopecia as an Adverse Event to Isotretinoin
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Guidelines for the Use of Acitretin in Psoriasis
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database
- Hair Care Cosmetics Regulation in Different Countries – A Comparative Study
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Proposed mechanisms of low-level light therapy in the treatment of androgenetic alopecia
- Discrimination and Proper Use of Polygoni Multiflori Radix, Cynanchi Wilfordii Radix, and Cynanchi Auriculati Radix in Korea: A Descriptive Review
- A Brief Review on Acne Vulgaris: Chronic Inflammatory Disease
- Practical and Theoretical Distinctions between Drugs and Cosmetics
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Low-level light therapy and hair loss
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Minoxidil tópico o minoxidil oral en la alopecia. ¿Cuál es su elección?
- Sunscreen: Cosmetic or medical therapy?
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Sun behaviors and quality of life after first cutaneous melanoma diagnosis